Optimer^® enhanced cell targeting & biomarker discovery

Choosing the right affinity ligand is the key to success in cell and tissue applications. Lack of reagent compatibility with cell and tissue-based applications can limit your science.

Find out how Optimer discovery uses cell and tissue screens to:

• Derisk the discovery process making sure your Optimer binds to the target in your application
• Deliver the highest performance binders with live or fixed samples included in discovery
• Reveal new biomarkers through cell phenotype directed screens
• Overcome protein target supply issues with Optimer cell screens

Download the application note to find out more about the Optimer cell discovery process and see the data from both target-directed and phenotype-directed applications in better IHC reagents, targeted delivery of oligonucleotide therapies, and new flow cytometry reagents for understanding the biology of different cancers.